Page 827 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

INDEX INDEX 783

natalizumab for, 122 HLA subtype association, 100 drugs causing, 444 Nails
recombinant cytokines for, 121 neostigmine for, 240 hydroxyurea, 442 clubbing, 60
Mumps, 170 as paraneoplastic syndrome, 228 irinotecan/topotecan, 442 glomus tumors under, 478
acute pancreatitis with, 397 pyridostigmine for, 240 Myenteric plexus, 362 hemorrhages in bed of, 311
paramyxovirus, 167, 169 restrictive lung diseases, 675 Mylohyoid muscle, 620 with psoriatic arthritis, 469
Munchausen syndrome, 566 MYCL1 gene, 224 Myocardial action potential, 292 Naïve T cell activation, 103
Munchausen syndrome by proxy, 566 MYCN gene, 224 Myocardial depression, 550 Naked viral genome infectivity, 163
Murphy sign, 396 Mycobacterial cells, 196 Myocardial infarction (MI), 304 Nalbuphine, 551
Muscarinic acetylcholine (ACh) Mycobacterium spp, 140 antiarrhythmics after, 322 Naloxone
receptors, 236 Gram stain, 125 β-blockers for, 245 dextromethorphan overdose, 686
Muscarinic agonists, 237 intracellular organism, 127 complications of, 307 heroin detoxification, 576
Muscarinic antagonists, 237, 241, 687 Ziehl-Neelsen stain, 125 diabetes mellitus, 346 for opioid toxicity, 248, 551
multiple sclerosis, 523 Mycobacterium avium-intracellulare, diagnosis of, 306 opioid toxicity, 570
neuromuscular blocking drugs, 140 on ECG, 293 Naltrexone
550, 551 HIV-positive adults, 177 ECG localization of STEMI, 306 alcoholism, 571
Parkinson disease, 548 prophylaxis with HIV, 198 evolution of, 305 heroin detoxification, 576
Muscarinic receptor vertebral osteomyelitis, 180 heart failure caused by, 309 opioid toxicity, 551
detrusor muscle, in, 237 Mycobacterium leprae heparin for, 436 2-naphthylamine, 225
Muscle conduction/contraction animal transmission, 149 homocystinuria, 84 Naproxen, 486
skeletal, 456 diagnosis, 141 hypertensive emergency and, 300 acute gout drugs, 487
smooth muscle, 457 rifamycins/dapsone, 196 shock caused by, 310 Narcissistic personality disorder, 565
Muscle proprioceptors, 458 Mycobacterium marinum, 140 thrombolytics for, 437 Narcolepsy
Muscles Mycobacterium pneumoniae, 126 Myocardial O consumption/ amphetamines for, 242
2
atrophy of, 42 Mycobacterium scrofulaceum, 140 demand, 284 characteristics/treatment, 568
in starvation, 91 Mycobacterium spp angina treatment, 319 hypnagogic/hypnopompic
metabolism in, 86 facultative intracellular organisms, Myocarditis, 313 hallucinations, 568
ragged red fibers in, 59 127 adenovirus, 164 Narrow-angle glaucoma, 536
Muscle spindled, 458 Mycobacterium tuberculosis coxsackievirus, 167 Nasal congestion, 686
Muscular dystrophies, 61 culture requirements for, 126 diphtheria, 139 Nasal decongestion
frameshift mutation, 61 osteomyelitis, 180 picornaviruses, 167 ephedrine for, 242
X-linked recessive disorder, 61 reactivation site, 140 Toxocara canis, 159 Nasal polyps
Muscularis externa, 362 symptoms of, 140 Myoclonic seizures, 517 cystic fibrosis, 60
Muscular ventricular septum, 281 therapeutic agents, 196, 197 Myoclonus, 519, 521 Nasal septum perforation, 315
Musculocutaneous nerve Mycolic acid Myofibroblasts, 216 Nasopharyngeal carcinoma
injury presentation, 447 isoniazid, 197 Myoglobin, 665 EBV and, 165
Musculoskeletal drug reactions, 250 synthesis of, 196 ooxygen-hemoglobin dissociation oncogenic microbes and, 226
Musculoskeletal paraneoplastic Mycology, 151–154 curve, 666 Natalizumab, 122
syndromes, 228 Mycophenolate mofetil, 120 Myoglobinuria multiple sclerosis, 523
Musculoskeletal system inosine monophosphate acute tubular necrosis, 602 Nateglinide, 353
anatomy, 446–454 dehydrogenase inhibition, 36 McArdle disease, 87 National Board of Medical Examiners
common conditions, 461 Mycoplasma spp Myonecrosis, 138 (NBME), 2, 11
pathology, 459–467 atypical organisms, 179 Myopathy Natriuresis, 588
pharmacology, 485–487 Gram stain, 125 daptomycin, 195 Natriuretic peptide, 296
Mutase, 73 macrolides, 193 drug reaction and, 250 Natural killer (NK) cells, 101, 409
Mutations pneumonia caused by, 150, 179, 683 Myophosphorylase, 87 cell surface proteins, 110
BRAF, 432 tetracyclines, 192 Myopia, 535 function of, 409
BRCA1 gene, 56 Mycoses retinal detachment, 537 innate immunity, 99
COL3A1, 51 cutaneous, 152 Myotonic dystrophy, 61 Nausea
de novo, 62 systemic, 151 cataracts and, 535 adverse drug effects, 400
drug resistance mechanisms, 196 Mycosis fungoides, 430 Myxedema antiemetics for, 401
in HbS and HbC, 410 Mydriasis thyroid hormones for, 354 with appendicitis, 383
JAK2, 433 glaucoma treatment and, 552 Myxomas, 316 biliary colic, 396
locus heterogeneity in, 57 G-protein-linked second receptor, Myxomatous degeneration, 291 with MI, 305
muscular dystrophies, 61 238 migraine headaches, 518
myelodysplastic syndromes, 432 muscarinic antagonists for, 241 N ranolazine, 319
non-Hodgkin lymphoma, 430 pupillary control, 539 N-acetylglucosaminyl-1- renal failure, 603
in PBPs, 187 saccular aneurysm, 516 phosphotransferase, 47 vitamin A toxicity, 66
same locus, 57 Myelencephalon, 490 N-acetylcysteine, 686 vitamin C toxicity, 69
STAT3, 116 Myelin, 494 for acetaminophen toxicity, 248 Nebivolol, 245
thalassemia and, 418 Myeloblasts (peripheral smear), 432 for cystic fibrosis, 60 Necator spp
tumor suppressor genes, 46, 525 Myelodysplastic syndromes, 432 NADH (reduced nicotinamide disease associations, 161
WT1 deletion, 606 sideroblastic anemia, 419 adenine dinucleotide) infection routes, 158
Myalgias Myelofibrosis, 433 electron transport chain, 78 Necator americanus, 159
Ebola virus, 171 Myeloid neoplasms, 432 fructose metabolism, 80 Neck and head cancer, 671
fluoroquinolones, 195 Myelomeningocele, 63, 492 TCA cycle, 77 cetuximab for, 442
genital herpes, 184 Myeloperoxidase, 109 Nadolol, 245 Necrosis, 209
Jarisch-Herxheimer reaction, 148 H O degradation, 128 NADPH (reduced nicotinamide acute pancreatitis, 397
2
2
Leptospira interrogans, 147 in neutrophils, 406 adenine dinucleotide Arthus reaction, 113
Lyme disease, 146 Myeloproliferative disorders phosphate) benign tumors, 220
meningitis, 186 in AML, 432 ethanol metabolism, 72 Budd-Chiari syndrome, 392
Trichinella spiralis, 159, 161 chronic, 433 HMP shunt and, 79 calcification, 211
trichinosis, 159 hydroxyurea for, 442 respiratory burst and, 109 enterocolitis, 386
vasculitides, 314 Myeloschisis, 491 universal electron acceptors, 75 femoral head, 120, 461, 463
Myasthenia gravis, 472 Myelosuppression Naegleria fowleri, 156 fibrinoid, 466
autoantibody, 115 alkylating agents, 441 Nafcillin glioblastoma multiforme, 526
diagnosis of, 240 antimetabolites, 440 characteristics of, 188 hepatic, 485

FAS1_2019_21_Index_749-806.indd 783 11/21/19 12:27 PM